Erny-Albrecht, K., & Erdmann, E. (2009). Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting. Swiss Medical Weekly, 139(1112), 173–173. https://doi.org/10.4414/smw.2009.12381